Results: KNB

Search articles by EPIC code
EPIC KNB
views

Kanabo – Cannabis Production Agreement but the high is already surely over

Newly (rushed) sub-Standard Listed Kanabo (KNB) has announced a cannabis production agreement with PharmaCann Polska, which is to supply cartiges containing Kanabo’s proprietry medicial cannabis for its VapePod inhalation device. The shares are up by 11% (last seen) on the news, to 20.5p – a long way off the ridiculous (ahem) high of over 40p at the IPO - valuing the company at some £47 million. That’s surely nonsense!

EPIC KNB
views

You’d need to be smoking uber strong Ganja to buy this bollocks from joke pot play Kanobo

Shares in Kanabo (KNB) have quadrupled to 25.5p since it raised £6 million as part of an RTO a week ago and this company, with zero sales and perhaps £4 million in the bank, is now valued at £92 million... you’d need to be smoking serious weed to buy that. But now, after just a week, we get the first announcement of just mind-blowing bollocks showing what a total spoof this all is.

EPIC KNB
views

Kanabo – a new pot IPO flies to the moon but how bad will the hangover be?

There is a flurry of new cannabis listings going on at the moment, and Peterhouse play Kanabo (KNB) joined the Standard List yesterday, having reversed into Spinnaker Opportunities – a cash shell which joined the sub-Standard list back in 2017. The RTO was accompanied by a placing, raising £6 million gross at 6.5p and the stock is, ahem, on a high at 17.25p giving a market capitalisation of a very tasty £62 million. So is it a buy or a bargepole?

Page 1 of 1 (8 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|